Whats new

Whats new.

Jefferies - Median 35.5 month OS in 1L metastatic NSCLC. Rated Buy, A$1 tgt (Analyst: Dr David Stanton)

October 23rd 2023

For a copy of this research report please contact your Jefferies advisor

Go back